The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.
The Cool Down on MSN22h
Researchers sound alarm over increased number of disease-carrying insects: 'This is a major concern'A new study shows that areas with domestic grazers are seeing a decline in spiders and an increase in grasshoppers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback